231 related articles for article (PubMed ID: 11194936)
21. Differential effects of COX inhibitors against beta-amyloid-induced neurotoxicity in human neuroblastoma cells.
Ferrera P; Arias C
Neurochem Int; 2005 Dec; 47(8):589-96. PubMed ID: 16169124
[TBL] [Abstract][Full Text] [Related]
22. Selective accumulation of cyclooxygenase-1-expressing microglial cells/macrophages in lesions of human focal cerebral ischemia.
Schwab JM; Nguyen TD; Postler E; Meyermann R; Schluesener HJ
Acta Neuropathol; 2000 Jun; 99(6):609-14. PubMed ID: 10867793
[TBL] [Abstract][Full Text] [Related]
23. Cyclo-oxygenase-2 inhibitors: rationale and therapeutic potential for Alzheimer's disease.
McGeer PL
Drugs Aging; 2000 Jul; 17(1):1-11. PubMed ID: 10933512
[TBL] [Abstract][Full Text] [Related]
24. Neurones treated with cyclo-oxygenase-1 inhibitors are resistant to amyloid-beta1-42.
Bate C; Veerhuis R; Eikelenboom P; Williams A
Neuroreport; 2003 Nov; 14(16):2099-103. PubMed ID: 14600505
[TBL] [Abstract][Full Text] [Related]
25. Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's disease brain.
Pasinetti GM; Aisen PS
Neuroscience; 1998 Nov; 87(2):319-24. PubMed ID: 9740394
[TBL] [Abstract][Full Text] [Related]
26. Microsomal prostaglandin E synthase-2: cellular distribution and expression in Alzheimer's disease.
Chaudhry U; Zhuang H; Doré S
Exp Neurol; 2010 Jun; 223(2):359-65. PubMed ID: 19664621
[TBL] [Abstract][Full Text] [Related]
27. Amyloid beta peptide (25-35) activates protein kinase C leading to cyclooxygenase-2 induction and prostaglandin E2 release in primary midbrain astrocytes.
Hüll M; Müksch B; Akundi RS; Waschbisch A; Hoozemans JJ; Veerhuis R; Fiebich BL
Neurochem Int; 2006 Jun; 48(8):663-72. PubMed ID: 16546299
[TBL] [Abstract][Full Text] [Related]
28. Activation of microglia and astrocytes: a roadway to neuroinflammation and Alzheimer's disease.
Kaur D; Sharma V; Deshmukh R
Inflammopharmacology; 2019 Aug; 27(4):663-677. PubMed ID: 30874945
[TBL] [Abstract][Full Text] [Related]
29. Cyclooxygenase-1 and -2 in brains of patients who died with sporadic Creutzfeldt-Jakob disease.
Deininger MH; Bekure-Nemariam K; Trautmann K; Morgalla M; Meyermann R; Schluesener HJ
J Mol Neurosci; 2003 Feb; 20(1):25-30. PubMed ID: 12663931
[TBL] [Abstract][Full Text] [Related]
30. Cyclooxygenase-2-dependent prostaglandin production by peripheral blood monocytes stimulated with lipopolysaccharides isolated from periodontopathogenic bacteria.
Noguchi K; Yanai M; Shitashige M; Nishihara T; Ishikawa I
J Periodontol; 2000 Oct; 71(10):1575-82. PubMed ID: 11063390
[TBL] [Abstract][Full Text] [Related]
31. Cyclooxygenases-1 and -2 are differentially localized to microglia and endothelium in rat EAE and glioma.
Deininger MH; Schluesener HJ
J Neuroimmunol; 1999 Mar; 95(1-2):202-8. PubMed ID: 10229132
[TBL] [Abstract][Full Text] [Related]
32. Cellular localization of cyclooxygenase-1 and cyclooxygenase-2 in the normal mouse, rat, and human retina.
Ju WK; Neufeld AH
J Comp Neurol; 2002 Oct; 452(4):392-9. PubMed ID: 12355421
[TBL] [Abstract][Full Text] [Related]
33. The role of COX-1 and COX-2 in Alzheimer's disease pathology and the therapeutic potentials of non-steroidal anti-inflammatory drugs.
Hoozemans JJ; O'Banion MK
Curr Drug Targets CNS Neurol Disord; 2005 Jun; 4(3):307-15. PubMed ID: 15975032
[TBL] [Abstract][Full Text] [Related]
34. Increased expression of cyclooxygenases and peroxisome proliferator-activated receptor-gamma in Alzheimer's disease brains.
Kitamura Y; Shimohama S; Koike H; Kakimura Ji; Matsuoka Y; Nomura Y; Gebicke-Haerter PJ; Taniguchi T
Biochem Biophys Res Commun; 1999 Jan; 254(3):582-6. PubMed ID: 9920782
[TBL] [Abstract][Full Text] [Related]
35. Selective inhibition of cyclooxygenase-2 expression by 15-deoxy-Delta(12,14)(12,14)-prostaglandin J(2) in activated human astrocytes, but not in human brain macrophages.
Janabi N
J Immunol; 2002 May; 168(9):4747-55. PubMed ID: 11971025
[TBL] [Abstract][Full Text] [Related]
36. Cytokines associated with amyloid plaques in Alzheimer's disease brain stimulate human glial and neuronal cell cultures to secrete early complement proteins, but not C1-inhibitor.
Veerhuis R; Janssen I; De Groot CJ; Van Muiswinkel FL; Hack CE; Eikelenboom P
Exp Neurol; 1999 Nov; 160(1):289-99. PubMed ID: 10630213
[TBL] [Abstract][Full Text] [Related]
37. Strong nuclear factor-kappaB-DNA binding parallels cyclooxygenase-2 gene transcription in aging and in sporadic Alzheimer's disease superior temporal lobe neocortex.
Lukiw WJ; Bazan NG
J Neurosci Res; 1998 Sep; 53(5):583-92. PubMed ID: 9726429
[TBL] [Abstract][Full Text] [Related]
38. Traumatic brain injury induces prolonged accumulation of cyclooxygenase-1 expressing microglia/brain macrophages in rats.
Schwab JM; Seid K; Schluesener HJ
J Neurotrauma; 2001 Sep; 18(9):881-90. PubMed ID: 11565600
[TBL] [Abstract][Full Text] [Related]
39. Hematopoietic prostaglandin D synthase and DP1 receptor are selectively upregulated in microglia and astrocytes within senile plaques from human patients and in a mouse model of Alzheimer disease.
Mohri I; Kadoyama K; Kanekiyo T; Sato Y; Kagitani-Shimono K; Saito Y; Suzuki K; Kudo T; Takeda M; Urade Y; Murayama S; Taniike M
J Neuropathol Exp Neurol; 2007 Jun; 66(6):469-80. PubMed ID: 17549007
[TBL] [Abstract][Full Text] [Related]
40. GFAP and vimentin deficiency alters gene expression in astrocytes and microglia in wild-type mice and changes the transcriptional response of reactive glia in mouse model for Alzheimer's disease.
Kamphuis W; Kooijman L; Orre M; Stassen O; Pekny M; Hol EM
Glia; 2015 Jun; 63(6):1036-56. PubMed ID: 25731615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
